Stay updated on Eteplirsen Safety in Early Duchenne Clinical Trial
Sign up to get notified when there's something new on the Eteplirsen Safety in Early Duchenne Clinical Trial page.

Latest updates to the Eteplirsen Safety in Early Duchenne Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded a prominent government funding status notice and an updated version tag (v3.2.0) while removing the old version tag (v3.1.0).SummaryDifference4%
- Check19 days agoChange DetectedUpdated the page from revision v3.0.2 to v3.1.0, signaling a new release version.SummaryDifference0.1%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedRevision updated to v3.0.2 (replacing v3.0.1) and the Back to Top element was removed; no other substantive changes were observed.SummaryDifference0.2%
- Check40 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%
- Check48 days agoChange DetectedThe web page has updated its facility name and location details, specifically adding 'St Louis, Missouri, United States, 63110' and 'eteplirsen' while removing previous mentions of related muscular dystrophy topics.SummaryDifference2%
- Check62 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Eteplirsen Safety in Early Duchenne Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eteplirsen Safety in Early Duchenne Clinical Trial page.